[Treatment of primary lesions in cancer of the mobile portion of the tongue. Experience of the Curie Institute (1959-1972)].
Six hundred and two patients were treated for carcinomas of the mobile portion of the tongue between 1959 and 1972. 16% were classified T1; 48% were classified T2; 36% were classified T3. 64% had no clinical signs of lymph node spread (NO). In the majority of cases the treatment of the primary lesion consisted of radium implantation, either alone or in association with external radiotherapy. Lymph nodes were treated chiefly by surgery. The absolute and determined survival at 5 years was 36% and 48%. Determined survival for lesions classified T1, T2 and T3 was respectively 80%, 56% and 25%. 70% of recurrences occurred during the first year. 13% of the patients who developed a tumour recurrence are living at 5 years. 33% of patients undergoing secondary surgery for recurrence were living at 5 years. 2% of patients developed necroses which were treated surgically.
D003131:Combined Modality Therapy; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D014062:Tongue Neoplasms / Q000401:mortality / Q000628:therapy*
Traitement de la lésion primaire dans les cancers de la langue mobile. Expérience de l'institut Curie (1959-1972).